Literature DB >> 1916061

The Fourth International Serum Exchange Workshop to standardize cytoplasmic islet cell antibodies. The Immunology and Diabetes Workshops and Participating Laboratories.

A Lernmark1, J L Molenaar, W A van Beers, Y Yamaguchi, S Nagataki, J Ludvigsson, N K Maclaren.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1916061     DOI： 10.1007/bf00403293

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  5 in total

1.  Progress toward standardization of cytoplasmic islet cell-antibody assay.

Authors:  H Gleichmann; G F Bottazzo
Journal:  Diabetes       Date:  1987-05       Impact factor: 9.461

2.  Immunology and Diabetes Workshop: report on the Third International (Stage 3) Workshop on the Standardisation of Cytoplasmic Islet Cell Antibodies. Held in New York, New York, October 1987.

Authors:  C Boitard; E Bonifacio; G F Bottazzo; H Gleichmann; J Molenaar
Journal:  Diabetologia       Date:  1988-07       Impact factor: 10.122

3.  Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies.

Authors:  E Bonifacio; A Lernmark; R L Dawkins
Journal:  J Immunol Methods       Date:  1988-01-21       Impact factor: 2.303

4.  Precision of the islet-cell antibody assay depends on the pancreas.

Authors:  M Landin-Olsson
Journal:  J Clin Lab Anal       Date:  1990       Impact factor: 2.352

5.  Plasmapheresis in the initial treatment of insulin-dependent diabetes mellitus in children.

Authors:  J Ludvigsson; L Heding; G Liedén; B Marner; A Lernmark
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-15
  5 in total
  18 in total

Review 1.  Immune intervention yes, but for what reason, for whom, when and how?

Authors:  A Lernmark
Journal:  Diabetologia       Date:  1992-11       Impact factor: 10.122

2.  Dietary manipulation of beta cell autoimmunity in infants at increased risk of type 1 diabetes: a pilot study.

Authors:  H K Akerblom; S M Virtanen; J Ilonen; E Savilahti; O Vaarala; A Reunanen; K Teramo; A-M Hämäläinen; J Paronen; M-A Riikjärv; A Ormisson; J Ludvigsson; H-M Dosch; T Hakulinen; M Knip
Journal:  Diabetologia       Date:  2005-04-19       Impact factor: 10.122

Review 3.  Autoantibodies in insulin-dependent diabetes mellitus.

Authors:  E Bosi; E Bonifacio
Journal:  J Endocrinol Invest       Date:  1994 Jul-Aug       Impact factor: 4.256

Review 4.  Italian serum exchange workshop for the standardization of organ specific autoantibodies. ImmunoEndocrinology Study Group of the Italian Society of Endocrinology.

Authors:  U Di Mario; C Betterle; F Dondero; G F Fenzi; S Mariotti; F Trimarchi
Journal:  J Endocrinol Invest       Date:  1994-05       Impact factor: 4.256

5.  Natural history of preclinical IDDM in high risk siblings. Childhood Diabetes in Finland Study Group.

Authors:  M Knip; P Vähäsalo; J Karjalainen; R Lounamaa; H K Akerblom
Journal:  Diabetologia       Date:  1994-04       Impact factor: 10.122

Review 6.  Immune therapy in type 1 diabetes mellitus.

Authors:  Ake Lernmark; Helena Elding Larsson
Journal:  Nat Rev Endocrinol       Date:  2013-01-08       Impact factor: 43.330

7.  Analysis of pancreas tissue in a child positive for islet cell antibodies.

Authors:  M Oikarinen; S Tauriainen; T Honkanen; K Vuori; P Karhunen; C Vasama-Nolvi; S Oikarinen; C Verbeke; G E Blair; I Rantala; J Ilonen; O Simell; M Knip; H Hyöty
Journal:  Diabetologia       Date:  2008-08-12       Impact factor: 10.122

8.  Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group.

Authors:  E Sabbah; K Savola; P Kulmala; H Reijonen; R Veijola; P Vähäsalo; J Karjalainen; J Ilonen; H K Akerblom; M Knip
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

9.  IA-2 antibody isotypes and epitope specificity during the prediabetic process in children with HLA-conferred susceptibility to type I diabetes.

Authors:  S Hoppu; T Härkönen; M S Ronkainen; S Simell; A Hekkala; A Toivonen; J Ilonen; O Simell; M Knip
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

10.  Inflammatory islet damage in patients bearing HLA-DR 3 and/or DR 4 haplotypes does not lead to islet autoimmunity.

Authors:  E F Lampeter; I Seifert; D Lohmann; J W Heise; J Bertrams; M R Christie; V Kolb-Bachofen; H Kolb
Journal:  Diabetologia       Date:  1994-05       Impact factor: 10.122
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.